WO2009140670A9 - Methods for assessing colorectal cancer and compositions for use therein - Google Patents
Methods for assessing colorectal cancer and compositions for use therein Download PDFInfo
- Publication number
- WO2009140670A9 WO2009140670A9 PCT/US2009/044282 US2009044282W WO2009140670A9 WO 2009140670 A9 WO2009140670 A9 WO 2009140670A9 US 2009044282 W US2009044282 W US 2009044282W WO 2009140670 A9 WO2009140670 A9 WO 2009140670A9
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compositions
- methods
- colorectal cancer
- assessing colorectal
- assessing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2725477A CA2725477A1 (en) | 2008-05-16 | 2009-05-18 | Methods for assessing colorectal cancer and compositions for use therein |
JP2011509787A JP2011520454A (en) | 2008-05-16 | 2009-05-18 | Methods for assessing colorectal cancer and compositions for use in such methods |
EP09747751A EP2283161A4 (en) | 2008-05-16 | 2009-05-18 | Methods for assessing colorectal cancer and compositions for use therein |
MX2010012542A MX2010012542A (en) | 2008-05-16 | 2009-05-18 | Methods for assessing colorectal cancer and compositions for use therein. |
BRPI0911972A BRPI0911972A2 (en) | 2008-05-16 | 2009-05-18 | methods for assessing colorectal cancer and compositions for their use |
IL209078A IL209078A0 (en) | 2008-05-16 | 2010-11-02 | Methods for assessing colorectal cancer and compositions for use therein |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5376008P | 2008-05-16 | 2008-05-16 | |
US61/053,760 | 2008-05-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009140670A2 WO2009140670A2 (en) | 2009-11-19 |
WO2009140670A9 true WO2009140670A9 (en) | 2010-03-18 |
Family
ID=41319374
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2009/044282 WO2009140670A2 (en) | 2008-05-16 | 2009-05-18 | Methods for assessing colorectal cancer and compositions for use therein |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP2283161A4 (en) |
JP (1) | JP2011520454A (en) |
KR (1) | KR20110015013A (en) |
BR (1) | BRPI0911972A2 (en) |
CA (1) | CA2725477A1 (en) |
IL (1) | IL209078A0 (en) |
MX (1) | MX2010012542A (en) |
WO (1) | WO2009140670A2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2814081A1 (en) * | 2010-10-08 | 2012-04-12 | Baylor Research Institute | Micrornas (mirna) as biomakers for the identification of familial and non-familial colorectal cancer |
JP5946466B2 (en) * | 2010-12-01 | 2016-07-06 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | Method for predicting colorectal cancer outcome by analyzing miRNA expression |
CN103384829A (en) * | 2011-01-13 | 2013-11-06 | 财团法人工业技术研究院 | Biomarkers for recurrence prediction of colorectal cancer |
NO3051026T3 (en) * | 2011-10-21 | 2018-07-28 | ||
JP6156621B2 (en) * | 2012-02-14 | 2017-07-05 | 国立大学法人 岡山大学 | Data acquisition method for ATLL diagnosis, ATLL diagnosis kit, and ATLL diagnosis system |
WO2013160474A2 (en) * | 2012-04-26 | 2013-10-31 | Instituto Aragonés De Ciencias De La Salud | miRNAs EXPRESSION IN HEMATOLOGICAL DISEASES |
US10260105B2 (en) | 2014-02-18 | 2019-04-16 | Baylor Research Institute | MiR-320e and colorectal cancer |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0818146A2 (en) * | 2007-10-30 | 2015-07-14 | Veridex Llc | Process to monitor colorectal cancer |
-
2009
- 2009-05-18 MX MX2010012542A patent/MX2010012542A/en not_active Application Discontinuation
- 2009-05-18 BR BRPI0911972A patent/BRPI0911972A2/en not_active IP Right Cessation
- 2009-05-18 JP JP2011509787A patent/JP2011520454A/en active Pending
- 2009-05-18 WO PCT/US2009/044282 patent/WO2009140670A2/en active Application Filing
- 2009-05-18 KR KR1020107028055A patent/KR20110015013A/en not_active Application Discontinuation
- 2009-05-18 EP EP09747751A patent/EP2283161A4/en not_active Withdrawn
- 2009-05-18 CA CA2725477A patent/CA2725477A1/en not_active Abandoned
-
2010
- 2010-11-02 IL IL209078A patent/IL209078A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR20110015013A (en) | 2011-02-14 |
IL209078A0 (en) | 2011-01-31 |
CA2725477A1 (en) | 2009-11-19 |
MX2010012542A (en) | 2010-12-21 |
WO2009140670A2 (en) | 2009-11-19 |
JP2011520454A (en) | 2011-07-21 |
BRPI0911972A2 (en) | 2019-09-24 |
EP2283161A2 (en) | 2011-02-16 |
EP2283161A4 (en) | 2012-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL2173379T3 (en) | Compositions and methods for treating and diagnosing cancer | |
HK1140944A1 (en) | Methods and compositions for treating recurrent cancer | |
EP2310526A4 (en) | Compositions for the detection and treatment of colorectal cancer | |
IL210153A0 (en) | Nutrigenomics methods and compositions | |
HK1148906A1 (en) | Compositions and methods for cancer treatment | |
IL212822A0 (en) | Anti-cxcr1 compositions and methods | |
GB0819530D0 (en) | Methods and compositions | |
HK1143157A1 (en) | 4-pyridinone compounds and their use for cancer 4- | |
EP2155249A4 (en) | Compositions and methods for diagnosing and treating cancer | |
EP2079839A4 (en) | Assessment of risk for colorectal cancer | |
EP2068618A4 (en) | Compositions and methods for cancer gene discovery | |
WO2009140670A9 (en) | Methods for assessing colorectal cancer and compositions for use therein | |
IL205248A0 (en) | Compositions and methods for making androstenediones | |
EP2035439A4 (en) | Assessment of risk for colorectal cancer | |
GB0811250D0 (en) | Methods and compositions | |
GB0822345D0 (en) | Methods and compositions for cancer prognosis | |
AU2014200650C1 (en) | Anti-CXCR1 compositions and methods | |
AU2008906027A0 (en) | Assessment of risk for colorectal cancer | |
AU2007906337A0 (en) | Assessment of risk for colorectal cancer | |
AU2007901147A0 (en) | Assessment of risk for colorectal cancer | |
AU2008903953A0 (en) | Methods and compositions | |
AU2008904402A0 (en) | Methods and compositions | |
IL210713A0 (en) | Compositions and methods for determininig the prognosis of bladder urothelail cancer | |
AU2007904579A0 (en) | Methods and compositions | |
AU2007900834A0 (en) | Methods and compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09747751 Country of ref document: EP Kind code of ref document: A2 |
|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2011509787 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2725477 Country of ref document: CA Ref document number: MX/A/2010/012542 Country of ref document: MX |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 20107028055 Country of ref document: KR Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009747751 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: PI0911972 Country of ref document: BR Kind code of ref document: A2 Effective date: 20101116 |